Physician profile
Jonathan Johnson
NPI 1992953749
$399,249.57
in general payments reported to CMS, 2019-2025
15 companies · $82K in 2025
The $82K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $19.08 · 2021: $103 · 2022: $446 · 2024: $317K · 2025: $82K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $317K · Consulting Fee: $81K · Food and Beverage: $735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $316,800.00 |
| Consulting Fee | $81,000.00 |
| Food and Beverage | $734.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $316,800.00 | 2024 | |
| Sanara Medtech INC. | $81,182.94 | 2025 | Celleraterx |
| Urgo Medical North America, LLC | $519.94 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Triad Life Sciences INC. | $176.35 | 2022 | |
| Nevro Corp. | $136.93 | 2022 | |
| Next Science LLC | $132.83 | 2022 | |
| Abbott Laboratories | $112.20 | 2019 | |
| Paratek Pharmaceuticals, INC. | $40.02 | 2020-2021 | |
| Medline Industries Lp | $34.17 | 2019 | |
| Acera Surgical, INC. | $25.30 | 2021 | |
| Hartmann USA, INC. | $20.20 | 2021 | |
| Organogenesis INC. | $18.69 | 2021 | |
| Mimedx Group, INC. | $18.41 | 2025 | |
| Smith+Nephew, INC. | $17.94 | 2021 | |
| Tactile Systems Technology INC | $13.65 | 2024 | Flexitouch Plus, Entre Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.